BACTERIAL SEPSIS AND MENINGITIS - Nizet Laboratory at UCSD

276 SECTION II Bacterial Infections
[603] M. Cetinkaya, et al., Comparison of serum amyloid A concentrations with
those of C-reactive protein and procalcitonin in diagnosis and follow-up of
neonatal sepsis in premature infants, J. Perinatol. 29 (2009) 225–231.
[604] E. Yapakci, et al., Serum pro-hepcidin levels in term and preterm newborns
with sepsis, Pediatr. Int. 51 (2009) 289–292.
[605] B.H. Yoon, et al., Interleukin-6 concentrations in umbilical cord plasma are
elevated in neonates with white matter lesions associated with periventricular
leukomalacia, Am. J. Obstet. Gynecol. 174 (1996) 1433.
[606] O. Dammann, A. Leviton, Maternal intrauterine infection, cytokines, and
brain damage in the preterm newborn, Pediatr. Res. 42 (1997) 1.
[607] S. Mehr, L.W. Doyle, Cytokines as markers of bacterial sepsis in newborn
infants: a review, Pediatr. Infect. Dis. J. 19 (2000) 879.
[608] T. Reier-Nilsen, et al., Comparison of broad range 16S rDNA PCR and
conventional blood culture for diagnosis of sepsis in the newborn: a case
control study, BMC. Pediatr. 9 (2009) 5.
[609] A. Ohlin, et al., Real-time PCR of the 16S-rRNA gene in the diagnosis of
neonatal bacteraemia, Acta Paediatr. 97 (2008) 1376–1380.
[610] K.Y. Chan, et al., Rapid identification and differentiation of gramnegative
and gram-positive bacterial bloodstream infections by quantitative
polymerase chain reaction in preterm infants, Crit. Care Med. 37 (2009)
2441–2447.
[611] L.H. Chen, et al., Rapid diagnosis of sepsis and bacterial meningitis in children
with real-time fluorescent quantitative polymerase chain reaction
amplification in the bacterial 16S rRNA gene, Clin. Pediatr. (Phila)
48 (2009) 641–647.
[612] M.L. Castor, et al., Antibiotic resistance patterns in invasive group B streptococcal
isolates, Infect. Dis. Obstet. Gynecol. (2008).
[613] S. Dahesh, et al., Point mutation in the group B streptococcal pbp2x gene
conferring decreased susceptibility to beta-lactam antibiotics, Antimicrob.
Agents Chemother. 52 (2008) 2915–2918.
[614] K. Kimura, et al., First molecular characterization of group B streptococci
with reduced penicillin susceptibility, Antimicrob. Agents Chemother.
52 (2008) 2890–2897.
[615] H.M. Swingle, R.L. Bucciarelli, E.M. Ayoub, Synergy between penicillins
and low concentrations of gentamicin in the killing of group B streptococci,
J. Infect. Dis. 152 (1985) 515.
[616] C.N. Baker, C. Thornsberry, R.R. Facklam, Synergism, killing kinetics, and
antimicrobial susceptibility of group A and B streptococci, Antimicrob.
Agents Chemother. 19 (1981) 716.
[617] V. Schauf, et al., Antibiotic-killing kinetics of group B streptococci,
J. Pediatr. 89 (1976) 194.
[618] A. Deveikis, et al., Antimicrobial therapy of experimental group B streptococcal
infection in mice, Antimicrob. Agents Chemother. 11 (1977) 817.
[619] R.J. Backes, et al., Activity of penicillin combined with an aminoglycoside
against group B streptococci in vitro and in experimental endocarditis,
J. Antimicrob. Chemother. 18 (1986) 491.
[620] C.M. Odio, et al., Comparative efficacy of ceftazidime vs. carbenicillin and
amikacin for treatment of neonatal septicemia, Pediatr. Infect. Dis. J.
6 (1987) 371.
[621] P. Begue, et al., Pharmacokinetics and clinical evaluation of cefotaxime in
children suffering from purulent meningitis, J. Antimicrob. Chemother.
14 (1984) 161.
[622] C.M. Odio, et al., Cefotaxime vs. conventional therapy for treatment of bacterial
meningitis of infants and children, Pediatr. Infect. Dis. J. 5 (1986) 402.
[623] C.M. Odio, Cefotaxime for treatment of neonatal sepsis and meningitis,
Diagn. Microbiol. Infect. Dis. 22 (1995) 111.
[624] J.S. Bradley, et al., Meropenem pharmacokinetics, pharmacodynamics, and
Monte Carlo simulation in the neonate, Pediatr. Infect. Dis. J. 27 (2008)
794–799.
[625] C.S. Bryan, et al., Gentamicin vs. cefotaxime for therapy of neonatal sepsis,
Am. J. Dis. Child. 139 (1985) 1086.
[626] P. Manzoni, et al., Risk factors for progression to invasive fungal infection in
preterm neonates with fungal colonization, Pediatrics 118 (2006)
2359–2364.
[627] D.K. Benjamin Jr., et al., Neonatal candidiasis among extremely low birth
weight infants: risk factors, mortality rates, and neurodevelopmental outcomes
at 18 to 22 months, Pediatrics 117 (2006) 84–92.
[628] P. Man, et al., An antibiotic policy to prevent emergence of resistant bacilli,
Lancet 355 (2000) 973.
[629] R.D. Feigin, G.H. McCracken, J.O. Klein, Diagnosis and management of
meningitis, Pediatr. Infect. Dis. J. 11 (1992) 785.
[630] J.S. Bradley, et al., Once-daily ceftriaxone to complete therapy of uncomplicated
group B streptococcal infection in neonates: a preliminary report, Clin.
Pediatr. 31 (1992) 274.
[631] S.L. Kaplan, C.C. Patrick, Cefotaxime and aminoglycoside treatment of
meningitis caused by gram-negative enteric organisms, Pediatr. Infect. Dis.
J. 9 (1990) 810.
[632] Group B Streptococcal Infections in Pregnancy, American College of Gynecology,
Washington, DC, 1996.
[633] American Academy of Pediatrics Committee on Infectious Diseases and Committee
on Fetus and Newborn, Guidelines for prevention of group B streptococcal
(GBS) infection by chemoprophylaxis, Pediatrics 90 (1992) 775.
[634] Centers for Disease Control and Prevention, Prevention of perinatal group
B streptococcal: a public health perspective, MMWR. Morb. Mortal. Wkly.
Rep. 45 (1996) 1.
[635] American Academy of Pediatrics, Committee on Infectious Diseases/Committee
on Fetus and Newborn. Revised guidelines for prevention of earlyonset
group B streptococcal infection, Pediatrics 99 (1997) 489.
[636] S. Schrag, et al., Prevention of perinatal group B streptococcal disease:
revised guidelines from CDC, MMWR. Morb. Mortal. Wkly. Rep.
51 (2002) 1.
[637] I.P. Uy, et al., Changes in early-onset group B beta hemolytic streptococcus
disease with changing recommendations for prophylaxis, J. Perinatol.
22 (2002) 516.
[638] M.A. MacAulay, M. Abou-Sabe, D. Charles, Placental transfer of ampicillin,
Am. J. Obstet. Gynecol. 96 (1966) 943.
[639] H. Nau, Clinical pharmacokinetics in pregnancy and perinatology, II: penicillins,
Dev. Pharmacol. Ther. 10 (1987) 174.
[640] D.H. Adamkin, E. Marshall, L.B. Weiner, The placental transfer of ampicillin,
Am. J. Perinatol. 1 (1984) 310.
[641] B.S. Brozanski, et al., Effect of a screening-based prevention policy on prevalence
of early-onset group B streptococcal sepsis, Obstet. Gynecol.
95 (2000) 496.
[642] M.R. Moore, S.J. Schrag, A. Schuchat, Effects of intrapartum antimicrobial
prophylaxis for prevention of group-B-streptococcal disease on the incidence
and ecology of early-onset neonatal sepsis, Lancet Infect. Dis. 3 (2003) 201.
[643] S.J. Schrag, et al., Group B streptococcal disease in the era of intrapartum
antibiotic prophylaxis, N. Engl. J. Med. 342 (2000) 15.
[644] S.P. Gotoff, K.M. Boyer, Prevention of early-onset neonatal group B streptococcal
disease, Pediatrics 99 (1997) 866.
[645] E. Squire, B. Favara, J. Todd, Diagnosis of neonatal bacterial infection:
hematologic and pathologic findings in fatal and nonfatal cases, Pediatrics
64 (1979) 60.
[646] G.H. McCracken Jr., S.G. Mize, A controlled study of intrathecal antibiotic
therapy in gram-negative enteric meningitis of infancy. Report of the
Neonatal Meningitis Cooperative Study Group, J. Pediatr. 89 (1976) 66.
[647] G.H. McCracken Jr., S.G. Mize, N. Threlkeld, Intraventricular gentamicin
therapy in gram-negative bacillary meningitis of infancy, Lancet 1 (1980)
787.
[648] N. Koksal, et al., Meropenem in neonatal severe infections due to multiresistant
gram-negative bacteria, Indian J. Pediatr. 68 (2001) 15.
[649] M. Khaneja, et al., Successful treatment of late-onset infection due to
resistant Klebsiella pneumoniae in an extremely low birth weight infant using
ciprofloxacin, J. Perinatol. 19 (1999) 311.
[650] H.L. van den Oever, et al., Ciprofloxacin in preterm neonates: case report
and review of the literature, Eur. J. Pediatr. 157 (1998) 843.
[651] R. Wessalowski, et al., Multiple brain abscesses caused by Salmonella enteritidis
in a neonate: successful treatment with ciprofloxacin, Pediatr. Infect.
Dis. J. 12 (1993) 683.
[652] R.E. Levitz, R. Quintiliani, Trimethoprim-sulfamethoxazole for bacterial
meningitis, Ann. Intern. Med. 100 (1984) 881.
[653] Z. Spirer, et al., Complete recovery from an apparent brain abscess treated
without neurosurgery: the importance of early CT scanning, Clin. Pediatr.
(Phila) 21 (1982) 106.
[654] A.S. Daoud, et al., Lack of effectiveness of dexamethasone in neonatal bacterial
meningitis, Eur. J. Pediatr. 158 (1999) 230–233.
[655] M.S. Tekerekoglu, et al., Analysis of an outbreak due to Chryseobacterium
meningosepticum in a neonatal intensive care unit, New Microbiol.
26 (2003) 57.
[656] R. Lauterbach, M. Zembala, Pentoxifylline reduces plasma tumour necrosis
factor-alpha concentration in premature infants with sepsis, Eur. J. Pediatr.
155 (1996) 404.
[657] K.R. Schibler, et al., A randomized, placebo-controlled trial of granulocyte
colony-stimulating factor administration to newborn infants with neutropenia
and clinical signs of early-onset sepsis, Pediatrics 102 (1998) 6.
[658] P. Kocherlakota, E.F. LaGamma, Preliminary report: rhG-CSF may reduce
the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia,
Pediatrics 102 (1998) 1107.
[659] K. Bilgin, et al., A randomized trial of granulocyte-macrophage colonystimulating
factor in neonates with sepsis and neutropenia, Pediatrics
107 (2001) 36.
[660] A. Ahmad, et al., Comparison of recombinant granulocyte colonystimulating
factor, recombinant human granulocyte-macrophage colonystimulating
factor and placebo for treatment of septic preterm infants,
Pediatr. Infect. Dis. J. 21 (2002) 1061.
[661] A. Ohlsson, J.B. Lacy, Intravenous immunoglobulin for suspected or subsequently
proven infection in neonates, Cochrane Database Syst. Rev.
CD001239, (2004).
[662] INIS Study, International Neonatal Immunotherapy Study: non-specific
intravenous immunoglobulin therapy for suspected or proven neonatal sepsis:
an international, placebo controlled, multicentre randomised trial,
BMC Pregnancy Childbirth 8 (2008) 52.
[663] R. Bennet, et al., The outcome of neonatal septicemia during fifteen years,
Acta Paediatr. Scand. 78 (1989) 40.
[664] M.M. Placzek, A. Whitelaw, Early and late neonatal septicaemia, Arch. Dis.
Child. 58 (1983) 728.
[665] J. de Louvois, Septicaemia and Meningitis in the Newborn, John Wiley &
Sons, New York, 1990.
[666] G. Klinger, et al., Predicting the outcome of neonatal bacterial meningitis,
Pediatrics 106 (2000) 477.